The PARP1 Inhibitor Niraparib Represses DNA Damage Repair and Synergizes with Temozolomide for Antimyeloma Effects.

Shen, Hong-Yuan; Tang, Hai-Long; Zheng, Yan-Hua; Feng, Juan; Dong, Bao-Xia; Chen, Xie-Qun

Shen, Hong-Yuan; Tang, Hai-Long; Zheng, Yan-Hua; Feng, Juan; Dong, Bao-Xia; Chen, Xie-Qun.

Afiliação

Shen HY; Department of Hematology, Xijing Hospital, Air Force Medical University, Xi'an, 710032 Shaanxi, China.
Tang HL; Department of Hematology, Xijing Hospital, Air Force Medical University, Xi'an, 710032 Shaanxi, China.
Zheng YH; Department of Hematology, Xijing Hospital, Air Force Medical University, Xi'an, 710032 Shaanxi, China.
Feng J; Department of Hematology, Xijing Hospital, Air Force Medical University, Xi'an, 710032 Shaanxi, China.
Dong BX; Department of Hematology, Xijing Hospital, Air Force Medical University, Xi'an, 710032 Shaanxi, China.
Chen XQ; Department of Hematology, Xijing Hospital, Air Force Medical University, Xi'an, 710032 Shaanxi, China.

J Oncol ; 2022: 2800488, 2022.

Article em En | MEDLINE | ID: mdl-35422863

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: J Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google